Insider · CIK 0001423837

Bozigian Haig P.

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001423837

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-08	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Chief Development Officer	AAward	+532 sh	—	—	532
2021-02-08	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−824 sh	$116.85	−$96.3K	154,934
2021-02-08	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−1,395 sh	$116.78	−$163K	156,189
2021-02-08	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−1,623 sh	$116.79	−$190K	157,651
2021-02-08	NBIXNEUROCRINE BIOSCIENCES INC · Stock OptionA Award	Chief Development Officer	AAward	+3,188 sh	—	—	3,188
2021-02-08	NBIXNEUROCRINE BIOSCIENCES INC · Stock OptionA Award	Chief Development Officer	AAward	+3,504 sh	—	—	3,504
2021-02-05	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−704 sh	$113.79	−$80.1K	153,328
2020-11-12	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−2,257 sh	$90.74	−$205K	152,694
2020-08-05	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−2,257 sh	$118.89	−$268K	150,663
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−9,094 sh	—	—	0
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+18.1K sh	$81.05	+$1.46M	166,690
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+15.8K sh	$81.49	+$1.29M	164,466
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−18.6K sh	—	—	15,289
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−15.8K sh	—	—	13,340
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−15.8K sh	$114.94	−$1.82M	148,633
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−18.6K sh	$114.94	−$2.13M	148,633
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+9,094 sh	$35.99	+$327K	157,727
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+18.6K sh	$43.24	+$803K	167,204
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−18.1K sh	—	—	47,383
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−9,094 sh	$114.94	−$1.05M	148,633
2020-05-12	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−18.1K sh	$114.94	−$2.08M	148,633
2020-04-24	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−1,934 sh	$99.46	−$192K	148,633
2020-02-07	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−1,623 sh	$103.33	−$168K	146,641
2020-02-06	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Chief Development Officer	AAward	+2,430 sh	—	—	2,430
2020-02-06	NBIXNEUROCRINE BIOSCIENCES INC · Stock OptionA Award	Chief Development Officer	AAward	+15.3K sh	—	—	15,337
2020-02-06	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−1,395 sh	$101.56	−$142K	145,180
2020-02-05	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−1,342 sh	$103.00	−$138K	143,292
2020-02-05	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−704 sh	$103.06	−$72.6K	143,925
2019-07-30	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−25.6K sh	$43.24	−$1.11M	33,860
2019-07-30	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−18.8K sh	$91.74	−$1.72M	141,976
2019-07-30	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+25.6K sh	$43.24	+$1.11M	167,576
2019-07-30	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+18.8K sh	$32.99	+$619K	160,732
2019-07-30	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−25.6K sh	$93.52	−$2.39M	141,976
2019-07-30	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−18.8K sh	$32.99	−$619K	0
2019-07-15	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+30.7K sh	$32.99	+$1.01M	172,656
2019-07-15	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−30.7K sh	$87.50	−$2.68M	141,976
2019-07-15	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−30.7K sh	$32.99	−$1.01M	18,756
2019-07-11	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+100 sh	$32.99	+$3,299	142,076
2019-07-11	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−100 sh	$32.99	−$3,299	49,436
2019-07-11	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−100 sh	$87.59	−$8,759	141,976
2019-07-10	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+7,120 sh	$32.99	+$235K	149,096
2019-07-10	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−7,120 sh	$87.63	−$624K	141,976
2019-07-10	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−7,120 sh	$32.99	−$235K	49,536
2019-06-18	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−2,100 sh	$32.99	−$69.3K	56,656
2019-06-18	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+2,100 sh	$32.99	+$69.3K	144,076
2019-06-18	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−2,100 sh	$87.82	−$184K	141,976
2019-06-13	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,432 sh	$32.99	−$47.2K	58,756
2019-06-13	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−15.8K sh	$19.59	−$310K	0
2019-06-13	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Development Officer	SSale	−1,432 sh	$83.29	−$119K	141,976
2019-06-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+1,432 sh	$32.99	+$47.2K	143,408

Recent filings

Accepted (ET)
Mar 294/A
Bozigian Haig P.0001209191-21-023372
SEC(opens sec.gov)
Feb 94
Bozigian Haig P.0001209191-21-009130
SEC(opens sec.gov)
Nov 164
Bozigian Haig P.0001209191-20-058539
SEC(opens sec.gov)
Aug 74
Bozigian Haig P.0001209191-20-045742
SEC(opens sec.gov)
May 144
Bozigian Haig P.0001209191-20-029401
SEC(opens sec.gov)

Companies

NEUROCRINE BIOSCIENCES INCChief Development OfficerNBIX

Address

NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL

SAN DIEGO, CA, 92130